Open-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled Trial

被引：134
|
作者：
Kelley, John M. [1 ,2 ,3 ,4 ]
Kaptchuk, Ted J. [2 ,3 ]
Cusin, Cristina [3 ,4 ]
Lipkin, Samuel [3 ,4 ]
Fava, Maurizio [3 ,4 ]
机构：
[1] Endicott Coll, Dept Psychol, Beverly, MA 01915 USA
[2] Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA USA
来源：
PSYCHOTHERAPY AND PSYCHOSOMATICS | 2012年 / 81卷 / 05期
关键词：
D O I：
10.1159/000337053
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：312 / 314
页数：3
相关论文
共 50 条
  • [41] Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical Trial
    Belcher, Annabelle M.
    Cole, Thomas O.
    Massey, Ebonie
    Billing, Amy S.
    Wagner, Michael
    Wooten, William
    Epstein, David H.
    Hoag, Stephen W.
    Wickwire, Emerson M.
    Greenblatt, Aaron D.
    Colloca, Luana
    Rotrosen, John
    Magder, Lawrence
    Weintraub, Eric
    Wish, Eric D.
    Kaptchuk, Ted J.
    JAMA NETWORK OPEN, 2023, 6 (04) : E237099
  • [42] An open label clinical trial of reboxetine in patients with major depressive disorder
    Demir, B
    Soykan, A
    Devrimci-Ozguven, H
    Gögüs, A
    Haller, T
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S221 - S221
  • [43] Open-label Placebos for Wound Healing: A Randomized Controlled Trial
    Mathur, Ashwin
    Jarrett, Paul
    Broadbent, Elizabeth
    Petrie, Keith J.
    ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 (10) : 902 - 908
  • [44] The effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial
    Ellenbogen, Mark A.
    Cardoso, Christopher
    Serravalle, Lisa
    Vadaga, Kiran
    Joober, Ridha
    PSYCHOLOGICAL MEDICINE, 2024, 54 (09) : 2122 - 2132
  • [45] An open-label, flexible-dose study of memantine in major depressive disorder
    Ferguson, James M.
    Shingleton, Richard N.
    CLINICAL NEUROPHARMACOLOGY, 2007, 30 (03) : 136 - 144
  • [46] Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects
    Sezer, Dilan
    Locher, Cosima
    Gaab, Jens
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [47] Open-Label Placebo Treatment for Cancer-Related Fatigue: A Randomized-Controlled Clinical Trial
    Teri W. Hoenemeyer
    Ted J. Kaptchuk
    Tapan S. Mehta
    Kevin R. Fontaine
    Scientific Reports, 8
  • [48] Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects
    Dilan Sezer
    Cosima Locher
    Jens Gaab
    Scientific Reports, 12
  • [49] Effects of an open-label placebo intervention on reactions to social exclusion in healthy adults: a randomized controlled trial
    Leonie Stumpp
    Melissa Jauch
    Dilan Sezer
    Jens Gaab
    Rainer Greifeneder
    Scientific Reports, 13 (1)
  • [50] A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
    Lapidus, Kyle A. B.
    Levitch, Cara F.
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Soleimani, Laili
    Feder, Adriana
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    BIOLOGICAL PSYCHIATRY, 2014, 76 (12) : 970 - 976
12345